Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)

NCT04295551 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Lopinavir / ritonavir tablets combined with Xiyanping injection
DRUG: Lopinavir/ritonavir treatment

Sponsor

Jiangxi Qingfeng Pharmaceutical Co. Ltd.